Abstract
IntroductionFrom 2018 single inhaler triple therapy (SITT) became available in France to treat moderate-to-severe chronic obstructive pulmonary disease (COPD). Given its simplified inhaler use compared with multiple inhaler triple therapy...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have